文献速递头颈部肿瘤放疗中枢神经肿瘤放疗

基于MRI评分系统对鼻咽癌患者放射性鼻窦炎的临床评估

Clinical evaluation of radiation-induced sinusitis by MRI-based scoring system in nasopharyngeal carcinoma patients.
PubMed 文献 · Radiat Oncol · 2023-09-18

该回顾性分析收集346例鼻咽癌患者的临床与MRI数据,采用基于MRI的评分系统评估放射性鼻窦炎的发生规律、特征及影响因素并构建预测模型。结果显示放疗后6个月内鼻窦炎进展,6个月至2年趋于稳定并持续存在;吸烟史、放疗后时间和TNM分期为独立危险因素。

要点

  • 放疗后2年随访中两组L-M评分均显著变化,放疗后6个月起趋于平台。
  • 放疗后1、6、24个月鼻窦炎患病率在放疗前无鼻窦炎组为83%、91%、94%,有鼻窦炎组为93%、99%、98%。
  • 吸烟史(p=0.000)、放疗后时间(p=0.008)和TNM分期(p=0.040)为放射性鼻窦炎的独立危险因素。

核心结论

  • 放射性鼻窦炎是鼻咽癌患者放疗后常见并发症,放疗后6个月内进展,6个月至2年稳定并持续存在。
  • 放疗后上颌窦和筛窦炎症发生率高。
  • 吸烟史、放疗后时间和TNM分期是放射性鼻窦炎的显著独立危险因素。
  • 作者认为对模型中危险因素的干预可能预防或减少鼻咽癌患者放射性鼻窦炎的发生。

研究设计与样本

  • 回顾性分析,收集346例鼻咽癌患者的临床和MRI数据,分析放射性鼻窦炎的特征与预后。
  • 根据放射性鼻窦炎的影响因素构建预测模型。

主要发现

  • 放疗后2年随访中,放疗前有鼻窦炎组L-M评分显著变化(p=0.000),放疗前无鼻窦炎组亦显著变化(p=0.000)。
  • 放疗后6个月,放疗前有鼻窦炎组L-M评分趋于平台(p=0.311),放疗前无鼻窦炎组亦趋于平台(p=0.469)。
  • 放疗后1、6、24个月鼻窦炎患病率在放疗前无鼻窦炎组为83%、91%、94%,在放疗前有鼻窦炎组为93%、99%、98%。
  • 放疗前无鼻窦炎患者放疗后1个月上颌窦、前/后筛窦、蝶窦、额窦鼻窦炎发生率分别为87.1%、90.0%/87.1%、49.5%、11.8%。
  • 单因素和多因素分析显示与放射性鼻窦炎相关的因素为吸烟史(p=0.000)、放疗后时间(p=0.008)和TNM分期(p=0.040),并据此建立回归模型。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To explore the application of magnetic resonance imaging (MRI) in the evaluation of radiation-induced sinusitis (RIS), MRI-based scoring system was used to evaluate the development regularity, characteristics and influencing factors of RIS in nasopharyngeal carcinoma (NPC) patients. PATIENTS AND METHODS: A retrospective analysis was performed by collecting the clinical and MRI data of 346 NPC patients to analyze the characteristics and prognosis of RIS. The predictive model was constructed according to the influencing factors of RIS. RESULTS: (1) In the 2-year follow-up after radiotherapy (RT), there was significant change in L-M score in both groups of NPC patients (sinusitis before RT group: p = 0.000 vs. non-sinusitis before RT group: p = 0.000). After 6 months of RT, the L-M scores of the two groups tended to plateau (sinusitis before RT group: p = 0.311 vs. non-sinusitis before RT group: p = 0.469). (2) The prevalence of sinusitis in two groups of NPC patients (without or with sinusitis before RT) was 83% vs. 93%, 91% vs. 99%, 94% vs. 98% at 1, 6 and 24 months after RT, respectively. (3) In the patients without sinusitis before RT, the incidence of sinusitis in maxillary and anterior/posterior ethmoid, sphenoid and frontal sinuses was 87.1%, 90.0%/87.1%, 49.5%, 11.8% respectively, 1 month after RT. (4) A regression model was established according to the univariate and multivariate analysis of the factors related to RIS (smoking history: p = 0.000, time after RT: p = 0.008 and TNM staging: p = 0.040). CONCLUSION: (1) RIS is a common complication in NPC patients after RT. This disorder progressed within 6 months after RT, stabilized and persisted within 6 months to 2 years. There is a high incidence of maxillary sinus and ethmoid sinus inflammation in NPC patients after RT. (2) Smoking history, time after RT and TNM staging were significant independent risk factors for RIS. (3) The intervention of the risk factors in the model may prevent or reduce the occurrence of RIS in NPC patients.

来源:Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Zheng W, Yan T, Liu D, et al. Clinical evaluation of radiation-induced sinusitis by MRI-based scoring system in nasopharyngeal carcinoma patients. Radiat Oncol. 2023. PMID: 37723540. doi:10.1186/s13014-023-02331-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。